Diagnostics
Findings in diagnostics provide new insights
Published in Hepatitis Weekly, July 25th, 2005
Study 1: Gamma-glutamyltransferase marks excess liver activity in hepatitis C patients.
According to recent research published in the Journal of Viral Hepatitis, "serum gamma-glutamyltransferase (GGT) is considered as a sensitive but rather nonspecific marker of hepatobiliary disease, including chronic hepatitis C virus (HCV) infection. Although its increase in HCV infection is associated with poor response to interferon-alpha (IFN-alpha) and poor prognosis, there is little knowledge of the reasons of its increase during disease."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-07-25)
More Articles from Hepatitis Weekly
- Chronic Liver Disease
Three dimensional software enriches liver resection and transplantation - Endocrinology
Patients treated for chronic hepatitis C may develop thyroid dysfunction - Hepatitis B Vaccine
Non-invasive niosomes offer topical immunization against hepatitis B - Obstetrics
Immunological status influences hepatitis E severity in pregnant women - Transplant Medicine
Repeated pulse therapy increases graft loss in HCV-positive liver recipients - Allergy and Immunology
Lymphatic tissue does not support hepatitis B replication in carriers - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
